Dear Colleagues,

Below are pasted the minutes of the Standard sub-group for the PDDI DDI Minimum Information Model Task Force [1].


   Minutes for 4/29/2016 (Standard subgroup)


In Attendance : Matthias Samwald, Xia Jing, Brian LeBaron, Schneider, Jodi, Chris Vitale (PHS), Michael Miller, Oliver He, Kim Nolen, Øystein Nytrø, Oya Beyan, Richard Boyce, Mathias Brochhausen, Daniela & Ratnesh


Meeting recording: http://goo.gl/UTX6pY


Meeting:

 *

   Update from the Content subteam

     o

       The content workgroup has agreed upon 10 PDDIs to include:
       https://goo.gl/rYpmjt

         +

           These cover the following information aspects:

             #

               can (and should) be contextualized for specific patients
               or clinical circumstances,

             #

               applies at the class level, does not apply at the class
               level,

             #

               the mechanism is known and is pharmacokinetic, the
               mechanism is known and is pharmacodynamic

         +

           More forthcoming...

     o

       Decision trees useful for contextualizing the PDDIs, provide
       management options, and linking to relevant evidence will be
       created for all of them

         +

           Done already for 2 of the 10 now included

 *

   Toward writing an Interest Group Note

     o

       Rich re-organized the initial draft note to focus on
       introduction and background with stakeholder descriptions, use
       cases, and user scenarios

         +

           An github project and initial draft:

             #

               GitHub project: https://github.com/W3C-HCLS/w3c-ddi

             #

               Example draft : http://goo.gl/7ZaE94

     o

       Rich created google docs that we will write in and then the
       editors will migrate the content into the W3C note format

         +

           These are linked to from the http://goo.gl/7ZaE94 and also
           listed here:

             #

               Introduction and motivation for the  W3C DDI Minimum
               Information Model IG Note <https://goo.gl/YWRMV3>

             #

               Stakeholder Descriptions
               
<https://docs.google.com/document/d/1AbWuONYTrFOV95OhjlRwrm3ZJy5jjvzJ-dywO5OZyFY/edit#>

             #

               DDI Minimum Information Model User Scenarios
               
<https://docs.google.com/document/d/1HE8r8nmJBHRrtbE6YrNfK00Ztkev44-dNk-Rm6MP92U/edit>

             #

               Knowledge Representation Core Considerations
               
<https://docs.google.com/document/d/14saXL4qhusPHxxN1Aymc5z_u7vH3j3V-YF9TKNjRxLQ/edit>


 *

   Progress on definitions

     o

       Discussion of stakeholders

         +

           Rich has pulled this into two google docs in the format of
           user profile and scenarios for discussion by the sub-team
           with the goal of finalizing by the next call

             #

               Stakeholder Descriptions
               
<https://docs.google.com/document/d/1AbWuONYTrFOV95OhjlRwrm3ZJy5jjvzJ-dywO5OZyFY/edit#>and
               DDI Minimum Information Model User Scenarios
               
<https://docs.google.com/document/d/1HE8r8nmJBHRrtbE6YrNfK00Ztkev44-dNk-Rm6MP92U/edit>

                 *

                   He will send a request to complete a qualtrics
                   survey eliciting feedback on each user scenario

     o

       We agreed as a team to use the following process for moving the
       current suggested definitions
       
<https://docs.google.com/spreadsheets/d/1dhUp496riwZ0AHqRP7I85oEvuP2jjEI0rcw1Fcm2zI8/edit#gid=0>to
       final definitions as follows:

         +

           For a given information category (e.g., clinical
           consequences) Rich will summarize the currently suggested
           candidate definitions

             #

               Including any references to the terminologies or
               publications where they came from

             #

               He will also show examples of the definitions from the
               contextualizing decision trees created for the included
               interactions
               
<https://docs.google.com/spreadsheets/d/1DIeIuo7tZ6nVvd6MdO2xzzLtOSPXjAHI-DdBe9M3kiw/edit>

         +

           Rich will create a qualtrics survey for each summary to
           elicit agreement on a final proposed definition

             #

               This process likely be iterative


 *

   Knowledge representation goal for the model

     o

       We reviewed Knowledge Representation Core Considerations
       
<https://docs.google.com/document/d/14saXL4qhusPHxxN1Aymc5z_u7vH3j3V-YF9TKNjRxLQ/edit>
 which
       is meant to suggest the scope of formalization for the minimum
       information model

         +

           It was agreed that we need to define what we mean by
           information model and convert those notes to a couple of
           concise paragraphs that declare the scope of formalization
           for the model and how definitions will be created, accepted,
           and revised (if needed).

             #

               Mathias Brochhausen will lead a sub-team this month to
               finalize these decisions and develop this write up

                 *

                   Oya, Oliver, Daniela & Ratnesh, and Øystein
                   volunteered to participate

                     o

                       Invitations will go out to others who could not
                       attend the call

 *

   Next steps

     o

       All will complete doodles to schedule new meetings for the next
       few months

     o

       A sub-team led by Mathias B. will develop a statement that
       clarifies  the scope of formalization for the minimum
       information model and process for creating/accepting/revising
       definitions

     o

       We will implement the process process for
       creating/accepting/revising definitions


--
Richard D Boyce, PhD
Assistant Professor of Biomedical Informatics
Faculty, Center for Pharmaceutical Policy and Prescribing
Faculty, Geriatric Pharmaceutical Outcomes and Gero-Informatics Research and 
Training Program
University of Pittsburgh
rd...@pitt.edu
Office: 412-648-9219
Twitter: @bhaapgh

Reply via email to